Liver fibrosis is a significant medical condition characterized by the abnormal accumulation of fibrous tissue in the liver and can lead to cirrhosis. A deeper understanding of the biological processes that drive liver fibrosis is crucial for the development of more effective diagnostic and therapeutic strategies. Long non-coding RNAs (lncRNAs) have emerged as key regulators in the development of liver fibrosis and may serve as promising targets for future therapies. This article examines the involvement of lncRNAs in liver fibrosis, explores the mechanisms of their pathogenic effects, and also investigates their potential for use as diagnostic tools and therapeutic targets. The discovery and investigation of these lncRNAs could pave the way for innovative approaches to the diagnosis and treatment of liver fibrosis. However, further research is needed to fully comprehend the molecular interactions between lncRNAs and liver fibrosis and to evaluate their viability as biomarkers and therapeutic candidates.
